NextPoint Therapeutics, Inc.
McKenna Lamb is a Senior Research Scientist at NextPoint Therapeutics, Inc. since October 2020, and previously served as a Research Associate at the same company. Prior experience includes a role as a Research Assistant in the McMenimen Lab at Mount Holyoke College from May 2018 to December 2019, focusing on protein biochemistry and small heat shock proteins. McKenna also worked as a Research Assistant at Dana-Farber Cancer Institute during the summer of 2019, where responsibilities included screening follicular lymphoma patient-derived xenografts using ultrasound techniques. McKenna holds a Bachelor's degree in Biochemistry from Mount Holyoke College, earned in December 2019.
NextPoint Therapeutics, Inc.
NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients. The company offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems to find and destroy cancer cells.